NASDAQ:WBA - Walgreens Boots Alliance Stock Price, News, & Analysis

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Walgreens Boots Alliance announced a quarterly dividend on Monday, January 28th. Stockholders of record on Friday, February 15th will be given a dividend of $0.44 per share on Tuesday, March 12th. This represents a $1.76 annualized dividend and a dividend yield of 2.40%. The ex-dividend date is Thursday, February 14th. View Walgreens Boots Alliance's Dividend History.

Walgreens Boots Alliance declared that its board has initiated a stock repurchase plan on Thursday, October 26th 2017, which authorizes the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company's management believes its shares are undervalued.

Walgreens Boots Alliance Inc (NASDAQ:WBA) issued its earnings results on Thursday, December, 20th. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.43 by $0.03. The pharmacy operator earned $33.79 billion during the quarter, compared to analyst estimates of $33.90 billion. Walgreens Boots Alliance had a net margin of 3.96% and a return on equity of 22.17%. The business's revenue for the quarter was up 9.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.28 EPS. View Walgreens Boots Alliance's Earnings History.

Walgreens Boots Alliance is scheduled to release their next quarterly earnings announcement on Wednesday, March 27th 2019. View Earnings Estimates for Walgreens Boots Alliance.

Walgreens Boots Alliance updated its FY19 earnings guidance on Thursday, December, 20th. The company provided EPS guidance of $6.40-6.70 for the period, compared to the Thomson Reuters consensus estimate of $6.51. Walgreens Boots Alliance also updated its FY 2019 guidance to $6.44-6.74 EPS.

18 brokers have issued 1 year target prices for Walgreens Boots Alliance's stock. Their predictions range from $60.00 to $104.00. On average, they expect Walgreens Boots Alliance's share price to reach $77.8235 in the next twelve months. This suggests a possible upside of 6.0% from the stock's current price. View Analyst Price Targets for Walgreens Boots Alliance.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 3 sell ratings, 10 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Walgreens Boots Alliance.

News articles about WBA stock have trended somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Walgreens Boots Alliance earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media stories about the pharmacy operator a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future.

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Walgreens Boots Alliance's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.69%), Oregon Public Employees Retirement Fund (3.69%), Northern Trust Corp (1.23%), LSV Asset Management (1.23%), Geode Capital Management LLC (1.22%) and Bank of New York Mellon Corp (1.09%). Company insiders that own Walgreens Boots Alliance stock include John Anthony Lederer, Kathleen Wilson-Thompson, Kimberly R Scardino, Nancy M Schlichting, Ornella Barra, Stefano Pessina and William C Foote. View Institutional Ownership Trends for Walgreens Boots Alliance.

WBA stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Mackenzie Financial Corp, KBC Group NV, Scharf Investments LLC, Jarislowsky Fraser Ltd, Toronto Dominion Bank, California Public Employees Retirement System and DNB Asset Management AS. Company insiders that have sold Walgreens Boots Alliance company stock in the last year include Kathleen Wilson-Thompson, Kimberly R Scardino, Nancy M Schlichting and William C Foote. View Insider Buying and Selling for Walgreens Boots Alliance.

WBA stock was acquired by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Boston Partners, CI Investments Inc., Prudential Financial Inc., BlackRock Inc., Assenagon Asset Management S.A., Geode Capital Management LLC and Acadian Asset Management LLC. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include John Anthony Lederer, Ornella Barra and Stefano Pessina. View Insider Buying and Selling for Walgreens Boots Alliance.

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of WBA stock can currently be purchased for approximately $73.43.

Walgreens Boots Alliance has a market capitalization of $69.28 billion and generates $131.54 billion in revenue each year. The pharmacy operator earns $5.02 billion in net income (profit) each year or $6.02 on an earnings per share basis. Walgreens Boots Alliance employs 354,000 workers across the globe.

The official website for Walgreens Boots Alliance is http://www.walgreensbootsalliance.com.

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]